Related Experiment Video
Updated: Jul 16, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Serious complications from dislocation of a Watchman left atrial appendage occluder
Claudia Stöllberger1, Birke Schneider, Josef Finsterer
1Krankenanstalt Rudolfstiftung, 2. Medizinische Abteilung, Vienna, Austria. claudia.stoellberger@chello.at
Insights
Left atrial appendage occlusion using the Watchman device can lead to serious complications, as demonstrated by a case of device embolization requiring emergency surgery and resulting in heart failure. This highlights potential risks of percutaneous LAA occlusion.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Procedures
Background:
- Left atrial appendage (LAA) occlusion is a strategy to prevent stroke in patients with atrial fibrillation (AF).
- The Watchman occluder is a device used for percutaneous LAA occlusion, currently under investigation in the PROTECT AF trial.
Observation:
- A 78-year-old male patient experienced Watchman device embolization 10 minutes after implantation.
- The embolized device migrated to the aortic valve.
Findings:
- Emergency cardiac surgery was required for device removal from the aortic valve.
- The patient necessitated implantation of an aortic bioprosthesis and a pacemaker.
- One year post-surgery, the patient continued to experience heart failure.
Implications:
- Percutaneous LAA occlusion procedures carry risks of severe complications.
- This case underscores the importance of careful patient selection and procedural monitoring during LAA occlusion.
- Further research into device safety and management of complications is warranted.
Abstract:
Left atrial appendage (LAA) elimination is regarded to protect patients with atrial fibrillation (AF) from stroke or embolism. The Watchman occluder is a device for percutaneous LAA occlusion and is at present investigated in the PROTECT AF trial. In a 78-year-old man, embolization of the Watchman device occurred 10 minutes after implantation. At emergency cardiac surgery, the device was removed from the aortic valve and an aortic bioprosthesis and a pacemaker had to be implanted. One year postoperatively, he still suffers from heart failure. This case shows that percutaneous LAA occlusion may result in serious complications.
More Related Videos
Related Concept Videos
Aneurysm III: Interprofessional Care
Cardiac Catheterization II: Right Heart Catheterization
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Peripheral Artery Disease V: Postoperative Nursing Management
Rheumatic Heart Disease I: Introduction

